What is the debt of CardieX this year?
CardieX has a debt level of 3.38 AUD this year.
CardieX Debt 2024
CardieX Debt
3.38 AUD
Ticker
CDX.AX
ISIN
AU0000015729
WKN
A2JN9Z
In 2024, CardieX's total debt was 3.38 AUD, a -533.88% change from the -0.78 AUD total debt recorded in the previous year.
CardieX Aktienanalyse
What does CardieX do?
Cardiex Ltd is an Australian medical technology company specializing in the development and marketing of cardiovascular monitoring systems and diagnostic tools. The company was founded in 1996 and is based in Melbourne. Cardiex's history begins with the development of SphygmoCor technology in collaboration with researchers from Monash University. This technology allows for non-invasive measurement of pulse and blood pressure waves in the arteries, providing information about the condition of the cardiovascular system. Cardiex's first product was the SphygmoCor Analyzer, which was launched in 1999. Over time, additional products and technologies have been developed to meet the growing demand for cardiovascular monitoring and diagnostics. Cardiex's business model is based on the development and marketing of innovative medical technologies for the international market. The company works closely with clinics, research institutions, and medical device manufacturers to develop products that meet the needs of the healthcare sector. Cardiex has a comprehensive network of sales and marketing partners in over 40 countries worldwide. Cardiex operates in several divisions, including: - Diagnostic Systems: This division includes products such as the SphygmoCor Analyzer, which assesses arterial health, and the Arterial Stiffness Scanner, which enables early detection of cardiovascular risk factors. - Telemedicine: Cardiex offers a telehealth platform that allows clinics and medical personnel to monitor and analyze patient data in real-time. The platform can be used for remote patient monitoring, early detection of complications, and treatment optimization. - Research and Development: Cardiex collaborates closely with researchers and medical institutions to develop new technologies for cardiovascular monitoring and diagnostics. The company invests heavily in research and development to maintain a leading role in the field of medical technology. An important aspect of Cardiex's business model is its partnership with other companies. The company works closely with device manufacturers, software developers, and other service providers to integrate its technologies and products, offering complete solutions for the healthcare sector. Cardiex's products include not only the SphygmoCor Analyzer but also the Arterial Stiffness Scanner, Ambulatory Blood Pressure Monitor, CardiexCare data management system, and telehealth platform. All these products are designed to simplify and improve the monitoring and diagnosis of cardiovascular diseases. Overall, Cardiex is a successful medical technology company specializing in the development and marketing of innovative cardiovascular monitoring systems and diagnostic tools. The company has expanded its product and service offerings in recent years and has a strong international presence. Through close collaboration with other companies and research institutions, Cardiex will continue to play a leading role in the field of medical technology in the future. CardieX ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding CardieX's Debt Structure
CardieX's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing CardieX's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to CardieX’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in CardieX’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about CardieX stock
What was the debt of CardieX compared to the previous year?
The debt of CardieX has increased by -533.88% compared to the previous year dropped.
What are the consequences of high debt for investors in CardieX?
High debt can pose a risk for investors of CardieX, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of CardieX?
Low debt means that CardieX has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from CardieX affect the company?
An increase in debt of CardieX can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of CardieX affect the company?
A reduction in debt of CardieX can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of CardieX?
Some factors that can influence the debt of CardieX include investments, acquisitions, operating costs, and revenue development.
Why are the debts of CardieX so important for investors?
The debts of CardieX are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can CardieX take to change the debt?
To change the debt, CardieX can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does CardieX pay?
Over the past 12 months, CardieX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CardieX is expected to pay a dividend of 0 AUD.
What is the dividend yield of CardieX?
The current dividend yield of CardieX is .
When does CardieX pay dividends?
CardieX pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of CardieX?
CardieX paid dividends every year for the past 0 years.
What is the dividend of CardieX?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is CardieX located?
CardieX is assigned to the 'Health' sector.
Wann musste ich die Aktien von CardieX kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CardieX from 12/22/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 12/22/2024.
When did CardieX pay the last dividend?
The last dividend was paid out on 12/22/2024.
What was the dividend of CardieX in the year 2023?
In the year 2023, CardieX distributed 0 AUD as dividends.
In which currency does CardieX pay out the dividend?
The dividends of CardieX are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von CardieX
Our stock analysis for CardieX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CardieX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
